Studies have shown that the expression of FADS1 increases in brain cancers of primary tumors, and the underlying mechanism for FADS1-mediated tumor progression is that FADS1 affects the cholesterol synthesis process and cell cycle arrest 58-60. The gene discussed is FADS1; the disease is brain cancer.